Table 1. Anthropometric and biochemical effects of COPs on patients after surgery for 7 days.
| Total (N=141) | Baseline | 7 days after surgery | ΔP | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TI (N=50) | CI (N=91) | P | TI (N=50) | CI (N=91) | P | |||||
| Men (N=114), women (N=27) | Men (N=41), women (N=9) | Men (N=73), women (N=18) | Men (N=41), women (N=9) | Men (N=73), women (N=18) | ||||||
| Age (years) | 56.65±1.62 | 56.80±2.46 | 56.57±2.15 | 0.94 | ||||||
| Weight (kg) | 70.88±3.76 | 66.53±2.85 | 73.30±5.58 | 0.24 | ||||||
| BMI (kg/m2) | 25.86±4.30 | 23.94±0.89 | 24.06±0.86 | 0.11 | ||||||
| ALT (µ/L) | 27.96±3.31 | 27.94±4.71 | 27.96±4.45 | 0.58 | 72.48±16.50 | 105.13±23.89 | 0.01 | 0.04 | ||
| AST (µ/L) | 27.50±1.93 | 28.00±3.16 | 27.21±2.44 | 0.78 | 29.81±5.39 | 40.10±9.01 | 0.01 | 0.03 | ||
| TBIL (µmol/L) | 13.89±1.13 | 16.47±2.52 | 12.45±0.93 | 0.01 | 12.62±2.00 | 18.73±2.65 | 0.48 | 0.00 | ||
| DBIL (µmol/L) | 5.36±0.30 | 6.00±0.56 | 5.01±0.34 | 0.01 | 6.50±0.96 | 10.79±1.67 | 0.17 | 0.01 | ||
| Alb (g/L) | 44.83±0.63 | 45.16±1.13 | 44.65±0.74 | 0.22 | 34.71±2.05 | 34.47±1.09 | 0.88 | 0.34 | ||
| Pre-Alb (g/L) | 21.93±0.83 | 21.22±1.43 | 22.33±1.02 | 0.20 | 11.76±1.82 | 9.86±1.14 | 0.08 | 0.01 | ||
| CREA (µmol/L) | 76.25±2.60 | 77.06±5.01 | 75.81±2.96 | 0.21 | 67.57±7.05 | 82.10±24.67 | 0.88 | 0.18 | ||
| PTA (%) | 89.90±2.37 | 85.16±4.13 | 92.54±2.75 | 0.01 | 73.81±5.47 | 70.09±2.94 | 0.68 | 0.00 | ||
| TC (mmol/L) | 4.76±1.17 | 4.24±0.21 | 5.04±1.82 | 0.49 | 3.08±0.36 | 2.78±0.21 | 0.62 | 0.25 | ||
| TG (mmol/L) | 1.32±0.11 | 1.20±0.14 | 1.38±0.16 | 0.37 | 0.94±0.13 | 1.02±0.12 | 0.27 | 0.21 | ||
| BUN (mmol/L) | 5.42±2.62 | 5.11±0.40 | 5.34±0.32 | 0.92 | 4.16±0.38 | 4.43±0.31 | 0.89 | 0.60 | ||
| AFP (ng/mL) | 9.42 (3.66–100.20) | 10.09 (3.11–501.60) | 7.70 (3.45–58.20) | 0.93 | 5.18 (2.82–15.27) | 5.67 (2.87–17.32) | 0.95 | 0.15 | ||
| CA199 (µ/mL) | 17.48 (10.98–32.08) | 19.81 (13.70–33.23) | 17.37 (11.09–30.49) | 0.69 | 25.12 (11.13–36.18) | 23.62 (14.69–50.83) | 0.36 | 0.09 | ||
| WBC (109/L) | 5.66±0.30 | 5.47±0.44 | 5.77±0.39 | 0.40 | 7.38±1.46 | 8.99±0.83 | 0.19 | 0.77 | ||
| NE (109/L) | 3.39±0.92 | 3.30±0.37 | 4.28±1.41 | 0.14 | 5.31±1.10 | 6.73±0.75 | 0.10 | 0.87 | ||
| RBC (1012/L) | 4.73±0.09 | 4.78±016 | 4.71±0.12 | 0.38 | 3.66±0.38 | 3.59±0.16 | 0.09 | 0.91 | ||
| HGB (g/L) | 147.34±2.66 | 148.80±4.15 | 146.53±3.46 | 0.46 | 110.81±9.16 | 112.47±4.52 | 0.62 | 0.77 | ||
| PLT (109/L) | 175.61±10.48 | 174.57±16.62 | 176.19±13.55 | 1.00 | 180.29±43.18 | 181.33±23.02 | 0.86 | 0.30 | ||
| LY (109/L) | 2.35±1.47 | 1.67±0.17 | 2.73±2.29 | 0.58 | 1.32±0.34 | 3.22±3.99 | 0.17 | 0.26 | ||
Data subjected to normal distribution are presented as the mean ± standard deviation, otherwise expressed as median (inter quartile range). COPs, corn oligopeptides; TI, corn oligopeptides intervention group; CI, control group; P, student t-test, considered as significance when <0.05; ∆P, the comparison between the difference of two investigations in TI and the difference of two measurements in CI. BMI, body mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBIL, total bilirubin; DBIL, direct bilirubin; Alb, albumin; Pre-Alb, Prealbumin; CREA, creatinine; PTA, prothrombin time activity; TC, serum total cholesterol; TG, triglyceride; BUN, blood urea nitrogen; AFP, alpha fetoprotein; CA199, carbohydrate antigen199; WBC, white blood cell; NE, neutrophil; RBC, red blood cell; HGB, hemoglobin; PLT, platelet; LY, lymphocyte.